|
 |
Method and System for the Quantitative Chemical Speciation of Mercury and Other Toxic Pollutants
The invention is a portable flow-system device which includes a gold and/or sulfur nanoparticle-based substrate to capture a sample (air, water). The device is then mounted on a modified mass spectrometer to obtain both qualitative and quantitative chemical speciation date for mercury or other toxic pollutants contained in the sample.
|
|
Posted: 27 January 2010, McGill University, Canada
|
|
 |
|
|
|
|
Cariology Probe For Dental Examination
McGill University is seeking a company interested in developing and commercializing a new carious lesions detective probe (hand tool) for dental examination. A research team has designed a new probe for dental examination with specific features allowing for better detection of cavities.
|
|
Posted: 25 January 2010, McGill University, Canada
|
|
|
|
|
|
|
Short term stock market forecasting tool
McGill University researchers have developed a software program to make day to day predictions of stock price variations. The prediction algorithm is based on a new hypothesis about the predictability of stock prices: the “Live Market Hypothesis”. McGill University is looking for users to further test and validate the prediction model, and for...
|
|
Posted: 24 November 2009, McGill University, Canada
|
|
|
|
|
|
|
|
|
|
Novel Material For Non-volatile Phase Change Memory Devices
Phase change memory devices have been proposed as the next generation technology for non-volatile memory devices. Currently flash memory devices are the dominant technology. In flash memory, data is stored using an electrical charge. Whereas in phase change memory devices, data is stored as changes in the state of the material’s property....
|
|
Posted: 2 July 2009, McGill University, Canada
|
|
|
|
Novel Treatment of Viral Infections
The technology provides a radical approach to prevention or treatment of viral infections. Viral resistance and suppression of viral replication can be achieved by inhibiting the expression and/or activity of 4E-BP to induce or enhance the immune response.
|
|
Posted: 18 June 2009, McGill University, Canada
|
|
|
|
Novel Treatment for ALS and Acute Spinal Cord Injury
Fenretinide, a retinoic acid analog, normalizes lipid imbalance and inhibits inflammatory mediators. In animal models of spinal cord injury and ALS, fenretinide decreased oxidative stress and the associated inflammatory response which resulted in improved survival of neurons and enhanced motor performance.
|
|
Posted: 18 June 2009, McGill University, Canada
|
|
| |
|
|
